Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-28 Purchase |
2021-12-29 9:32 pm |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
100,000 | $0.5732 | $57,320 | 325,879 (Direct) |
View |
| 2021-12-27 Purchase |
2021-12-28 7:04 pm |
Nabriva Therapeutics plc | NBRV | Naftzger J. Christopher General Counsel and Corp Sec |
7,000 | $0.59 | $4,130 | 7,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-07-06 Tax Withholding |
2022-07-07 4:11 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
225 | $0.1822 | 312,641 (Direct) |
View |
| 2022-07-06 Tax Withholding |
2022-07-07 4:10 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
89 | $0.1822 | 361,611 (Direct) |
View |
| 2022-06-30 Tax Withholding |
2022-07-01 6:08 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
107 | $0.182 | 312,866 (Direct) |
View |
| 2022-06-30 Tax Withholding |
2022-07-01 6:06 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
61 | $0.182 | 361,700 (Direct) |
View |
| 2022-06-06 Tax Withholding |
2022-06-07 4:47 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
225 | $0.2 | 312,973 (Direct) |
View |
| 2022-06-06 Tax Withholding |
2022-06-07 4:46 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
89 | $0.2 | 361,761 (Direct) |
View |
| 2022-05-31 Tax Withholding |
2022-06-02 4:10 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
107 | $0.2066 | 313,198 (Direct) |
View |
| 2022-05-31 Tax Withholding |
2022-06-02 4:09 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
61 | $0.2066 | 361,850 (Direct) |
View |
| 2022-05-06 Tax Withholding |
2022-05-09 6:33 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
89 | $0.26 | 361,911 (Direct) |
View |
| 2022-05-06 Tax Withholding |
2022-05-09 6:32 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
225 | $0.26 | 313,305 (Direct) |
View |
| 2022-04-30 Tax Withholding |
2022-05-03 4:59 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
107 | $0.31 | 313,530 (Direct) |
View |
| 2022-04-30 Tax Withholding |
2022-05-03 4:58 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
61 | $0.31 | 362,000 (Direct) |
View |
| 2022-04-06 Tax Withholding |
2022-04-08 4:16 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
219 | $0.41 | 313,637 (Direct) |
View |
| 2022-04-06 Tax Withholding |
2022-04-08 4:15 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
89 | $0.41 | 362,061 (Direct) |
View |
| 2022-03-31 Tax Withholding |
2022-04-04 6:27 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
104 | $0.42 | 313,856 (Direct) |
View |
| 2022-03-31 Tax Withholding |
2022-04-04 6:26 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
61 | $0.42 | 362,150 (Direct) |
View |
| 2022-03-06 Tax Withholding |
2022-03-08 4:14 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
89 | $0.43 | 362,211 (Direct) |
View |
| 2022-03-06 Tax Withholding |
2022-03-08 4:12 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
263 | $0.43 | 313,960 (Direct) |
View |
| 2022-02-28 Tax Withholding |
2022-03-02 7:51 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
125 | $0.45 | 314,223 (Direct) |
View |
| 2022-02-28 Tax Withholding |
2022-03-02 7:50 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
61 | $0.45 | 362,300 (Direct) |
View |
| 2022-02-06 Tax Withholding |
2022-02-08 4:26 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
106 | $0.48 | 362,361 (Direct) |
View |
| 2022-02-06 Tax Withholding |
2022-02-08 4:25 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
263 | $0.48 | 314,348 (Direct) |
View |
| 2022-01-31 Tax Withholding |
2022-02-01 8:47 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
125 | $0.48 | 314,611 (Direct) |
View |
| 2022-01-29 Tax Withholding |
2022-02-01 8:47 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
10,766 | $0.45 | 314,611 (Direct) |
View |
| 2022-01-31 Tax Withholding |
2022-02-01 8:44 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
73 | $0.48 | 362,467 (Direct) |
View |
| 2022-01-29 Tax Withholding |
2022-02-01 8:44 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
3,483 | $0.45 | 362,467 (Direct) |
View |
| 2022-01-28 Option Award |
2022-02-01 6:40 pm |
N/A 2032-01-27 |
Nabriva Therapeutics plc | NBRV | Guico-Pabia Christine J. Chief Medical Officer |
107,200 | $0 | 107,200 (Direct) |
View |
| 2022-01-28 Option Award |
2022-02-01 6:39 pm |
N/A 2032-01-27 |
Nabriva Therapeutics plc | NBRV | Dolan Daniel Chief Financial Officer |
124,800 | $0 | 124,800 (Direct) |
View |
| 2022-01-28 Option Award |
2022-02-01 6:37 pm |
N/A 2032-01-27 |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
359,700 | $0 | 359,700 (Direct) |
View |
| 2022-01-28 Option Award |
2022-02-01 6:35 pm |
N/A 2032-01-27 |
Nabriva Therapeutics plc | NBRV | Naftzger J. Christopher General Counsel and Corp Sec |
94,800 | $0 | 94,800 (Direct) |
View |
| 2022-01-28 Option Award |
2022-02-01 6:34 pm |
N/A 2032-01-27 |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
140,100 | $0 | 140,100 (Direct) |
View |
| 2022-01-06 Tax Withholding |
2022-01-10 4:19 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
270 | $0.58 | 325,502 (Direct) |
View |
| 2022-01-06 Tax Withholding |
2022-01-10 4:18 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
110 | $0.58 | 366,023 (Direct) |
View |
| 2021-12-31 Tax Withholding |
2022-01-04 5:06 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
107 | $0.6 | 325,772 (Direct) |
View |
| 2021-12-31 Tax Withholding |
2022-01-04 5:05 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
63 | $0.6 | 366,133 (Direct) |
View |
| 2021-12-06 Tax Withholding |
2021-12-08 5:14 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
225 | $0.72 | 225,879 (Direct) |
View |
| 2021-12-06 Tax Withholding |
2021-12-08 5:13 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
92 | $0.72 | 366,196 (Direct) |
View |
| 2021-11-30 Tax Withholding |
2021-12-02 6:31 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
107 | $0.78 | 226,104 (Direct) |
View |
| 2021-11-30 Tax Withholding |
2021-12-02 6:28 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO |
63 | $0.78 | 366,288 (Direct) |
View |
| 2021-11-06 Tax Withholding |
2021-11-09 5:38 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer |
225 | $1.33 | 226,211 (Direct) |
View |